Last reviewed · How we verify

NCT04569149

Primordial Dwarfism Registry

Recruiting now Last updated 1 October 2025
What this trial tests

trial in MOPDII in 200 participants. Currently enrolling.

Timeline
11 March 2008
Primary endpoint
1 January 2030
1 January 2030

Quick facts

Lead sponsorNemours Children's Clinic
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment200
Start date11 March 2008
Primary completion1 January 2030
Estimated completion1 January 2030
Sites1 location across United States

Conditions studied

Sponsor

Nemours Children's Clinic

Who can join

Eligibility, any sex, with MOPDII or Meier-Gorlin Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this registry is to collect information on individuals with forms of microcephalic primordial dwarfism as well as related conditions. The study team hopes to learn more about these conditions and improve the care of people with them by establishing this registry.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Nemours Children's Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04569149.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing